Literature DB >> 10827267

High rate of GB virus type C/HGV transmission from mother to infant: possible implications for the prevalence of infection in blood donors.

J J Lefrère1, A Sender, B Mercier, M Mariotti, F Pernot, J C Soulié, A Malvoisin, M Berry, A Gabai, F Lattes, J C Galiay, C Pawlak, V de Lachaux, V Chauveau, G Hreiche, M Larsen, C Férec, F Parnet-Mathieu, F Roudot-Thoraval, Y Brossard.   

Abstract

BACKGROUND: Because GB virus type C(GBV-C)/HGV (GBV-C/HGV) is blood-borne and sexually transmitted, persons at risk of infection with such viruses have a high prevalence of GBV-C/HGV markers. However, adults with no apparent risk factors, such as blood donors, frequently are positive for GBV-C/HGV markers. Mother-to-infant transmission could explain this high prevalence, but it has been studied only through small series of GBV-C/HGV-infected mothers co-infected with HCV or HIV. STUDY DESIGN AND METHODS: To determine the rate of mother-to-infant transmission of GBV-C/HGV RNA in women who are HCV- or HIV-negative, a prospective study was performed in a cohort of 288 mothers screened for viral RNA and in the infants born to GBV-C/HGV-infected mothers.
RESULTS: Thirteen mothers (4.5%) were found positive for GBV-C/HGV RNA. Of the infants in whom at least one blood sample was collected between the third and the ninth months of life, 89 percent were positive for viral RNA. The majority of these newborns were negative for GBV-C/HGV RNA at birth and positive after the third month. The viral RNA titers of infants born to GBV-C/HGV-infected mothers appeared as elevated as those of their mothers. All the GBV-C/HGV-infected infants remained positive for viral RNA during the entire study period. No clinical events possibly linked to a primary GBV-C/HGV infection were reported in infants. Serum ALT level and blood count remained within normal values throughout the follow-up of all GBV-C/HGV-infected infants.
CONCLUSION: The frequency of mother-to-infant GBV-C/HGV transmission is elevated and could explain the high prevalence of GBV-C/HGV markers (viral RNA and E2 antibody) in adults at low risk for blood-borne or sexually transmitted viruses, such as blood donors.

Entities:  

Mesh:

Year:  2000        PMID: 10827267     DOI: 10.1046/j.1537-2995.2000.40050602.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  8 in total

1.  Prevalence of hepatitis G virus infection and homology of different viral strains in Southern China.

Authors:  Gang Li; Hui-Hui Ma; Geroge K K Lau; Yin-Kit Leung; Chun-Lan Yao; Yu-Tian Chong; Wen-Hui Tang; Ji-Lu Yao
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

2.  Hepatitis G virus exposure in dialysis patients.

Authors:  Ali Eslamifar; Rasool Hamkar; Amitis Ramezani; Farrokhlagha Ahmadi; Latif Gachkar; Somayeh Jalilvand; Ladan Adibi; Shahnaz Atabak; Ali Khameneh; Ramin Ghadimi; Arezoo Aghakhani
Journal:  Int Urol Nephrol       Date:  2007-09-05       Impact factor: 2.370

Review 3.  Hepatitis G virus.

Authors:  Vasiliy Ivanovich Reshetnyak; Tatiana Igorevna Karlovich; Ljudmila Urievna Ilchenko
Journal:  World J Gastroenterol       Date:  2008-08-14       Impact factor: 5.742

4.  Interactions Between GB Virus Type C and HIV.

Authors:  Sarah L. George; Sabina Wünschmann; James McCoy; Jinhua Xiang; Jack T. Stapleton
Journal:  Curr Infect Dis Rep       Date:  2002-12       Impact factor: 3.663

5.  Effect of human pegivirus route of transmission on the genetic distribution of the virus: an institution based cross-sectional study.

Authors:  Wubet Taklual; Shixing Tang; Wu Yue
Journal:  Virol J       Date:  2019-04-25       Impact factor: 4.099

6.  Screening of Hepatitis G and Epstein-Barr Viruses Among Voluntary non Remunerated Blood Donors (VNRBD) in Burkina Faso, West Africa.

Authors:  Issoufou Tao; Cyrille Bisseye; Bolni Marius Nagalo; Mahamoudou Sanou; Alice Kiba; Guzin Surat; Tegwindé Rebeca Compaoré; Lassina Traoré; Jean Baptiste Nikiema; Virginio Pietra; Jean-Didier Zongo; Jacques Simpore
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-09-02       Impact factor: 2.576

7.  GB Virus C (GBV-C) Infection in Hepatitis C Virus (HCV) Seropositive Women with or at Risk for HIV Infection.

Authors:  Jason T Blackard; Gang Ma; Jeffrey A Welge; Caroline C King; Lynn E Taylor; Kenneth H Mayer; Robert S Klein; David D Celentano; Jack D Sobel; Denise J Jamieson; Lytt Gardner
Journal:  PLoS One       Date:  2014-12-10       Impact factor: 3.240

8.  GB virus type C E2 protein inhibits human immunodeficiency virus type 1 Gag assembly by downregulating human ADP-ribosylation factor 1.

Authors:  Chenliang Wang; Christine L Timmons; Qiujia Shao; Ballington L Kinlock; Tiffany M Turner; Aikichi Iwamoto; Hui Zhang; Huanliang Liu; Bindong Liu
Journal:  Oncotarget       Date:  2015-12-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.